CiloTax StentTM - summitMD.com
CiloTax StentTM - summitMD.com
CiloTax StentTM - summitMD.com
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Anti-restenotic Effect<br />
DECLARE - Long and Diabetes Study<br />
Cilostazol (n=354)<br />
Control (n=351)<br />
Cilostazol (n=200)<br />
Control (n=200)<br />
Restenosis rate (%)<br />
20<br />
15<br />
10<br />
5<br />
Long lesion treated with DES<br />
11.2<br />
6.7<br />
P=0.104<br />
20<br />
15<br />
10<br />
5<br />
Diabetes treated with DES<br />
15.6<br />
8.0<br />
P=0.033<br />
0<br />
Cilostazol taken orally after DES implantation significantly<br />
reduced the rate of restenosis.<br />
0<br />
Lee SW, et al Am J Cardiol 2007;100:1103<br />
J Am Coll Cardiol 2008;51:1181
Change language